Vision and Philosophy

Medicine and ethics are inseparable. Since Hippocrates, this has been a consensus among responsible physicians in all fields. A consensus that is becoming more important than ever in the light of the revolutionary possibilities of future diagnostic and therapeutic procedures.

TICEBA - Company - Vision and Philosophy



We offer our clients a unique, valuable preventive health care measure for the future, while taking into account the latest international findings from science and research and meeting the highest international standards.



We offer diverse fields of activity to our staff, in which they are able to develop freely. Through open communication transparency and efficiency are to be cultivated. We thus cultivate a continuous development of our staff and are at the same time striving at a sustainable staff loyalty.

It is our first priority to fulfill our customers' wishes. We reach this target by way of open conversations, reliable consulting services and individual recommendations. Continuous development of our products and our product portfolio through well-founded research opens new chances and opportunities to our clients.

We are loyal and reliable towards our business partners. We strive towards continuous improvement through open, efficient and honest communication. The interests of both parties are to be taken into account and preserved.

Adhering to continuous quality as well as complying with regulations plays a decisive role for us. Only by diligent implementation of the set standards are we able to meet the enormous requirements of our products.



"Keeping and restoring the health of my patients shall be the first and foremost command of my actions". This key sentence of the "Declaration of Geneva", which every physician solemnly attests to upon entering his profession, is the foundation of our company. We feel particularly committed to these ethical principles and have therefore established the target of generating access to the medical progress of the future to be expected for everyone even today.

Clinical Trials

We are now also recruiting patients for further clinical studies in phase I/IIa with allogeneic ABCB5-positive (ABCB5+) mesenchymal stem cells for the following indications: chronic venous ulcers (CVU), diabetic foot ulcers (DFU) and peripheral arterial occlusive disease (PAOD). For more information click HERE.


Besides the authorization to manufacture a human medicinal product in accordance with § 13 (1) of the German Medicinal Products Act (AMG) for autologous mesenchymal stem cells, TICEBA is also authorized to manufacture a medicinal product for allogeneic mesenchymal as well as allogeneic limbal ABCB5 + stem cells following a recent extension. For more information click HERE.

The Story of Stem Cells

Review our category "The Story of Stem Cells" with the newest topic "Stem cells in wound healing" HERE.